275 related articles for article (PubMed ID: 36949298)
1. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease.
Abrishamdar M; Jalali MS; Yazdanfar N
Neurol Sci; 2023 Jul; 44(7):2277-2289. PubMed ID: 36949298
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
Vilaça-Faria H; Salgado AJ; Teixeira FG
Cells; 2019 Feb; 8(2):. PubMed ID: 30717429
[TBL] [Abstract][Full Text] [Related]
3. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment.
Heris RM; Shirvaliloo M; Abbaspour-Aghdam S; Hazrati A; Shariati A; Youshanlouei HR; Niaragh FJ; Valizadeh H; Ahmadi M
Stem Cell Res Ther; 2022 Jul; 13(1):371. PubMed ID: 35902981
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease.
Huang W; Zhang T; Li X; Gong L; Zhang Y; Luan C; Shan Q; Gu X; Zhao L
Neuroscience; 2024 Jun; 549():1-12. PubMed ID: 38705349
[TBL] [Abstract][Full Text] [Related]
5. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
d'Angelo M; Cimini A; Castelli V
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
[TBL] [Abstract][Full Text] [Related]
6. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
7. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J
J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187
[TBL] [Abstract][Full Text] [Related]
8. Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
Li Y; Li Z; Gu J; Xu X; Chen H; Gui Y
Neurosci Lett; 2022 Feb; 771():136414. PubMed ID: 34954117
[TBL] [Abstract][Full Text] [Related]
9. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by Human Dental Pulp Mesenchymal Stem Cells: From Billions to Nano.
Venugopal C; K S; Rai KS; Pinnelli VB; Kutty BM; Dhanushkodi A
Curr Gene Ther; 2018; 18(5):307-323. PubMed ID: 30209999
[TBL] [Abstract][Full Text] [Related]
12. An injectable conductive Gelatin-PANI hydrogel system serves as a promising carrier to deliver BMSCs for Parkinson's disease treatment.
Xue J; Liu Y; Darabi MA; Tu G; Huang L; Ying L; Xiao B; Wu Y; Xing M; Zhang L; Zhang L
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():584-597. PubMed ID: 30948095
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.
Paccosi E; Proietti-De-Santis L
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298496
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.
Park H; Chang KA
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review.
Chen Y; Shen J; Ke K; Gu X
Neurol Sci; 2020 May; 41(5):1051-1061. PubMed ID: 31919699
[TBL] [Abstract][Full Text] [Related]
17. Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson's Disease.
Sharma Y; Shobha K; Sundeep M; Pinnelli VB; Parveen S; Dhanushkodi A
CNS Neurol Disord Drug Targets; 2022; 21(1):62-76. PubMed ID: 33719979
[TBL] [Abstract][Full Text] [Related]
18. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
Datta I; Bhonde R
Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
[TBL] [Abstract][Full Text] [Related]
19. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease.
Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Akyüz L; Steiner B
Regen Med; 2015 May; 10(4):431-46. PubMed ID: 26022763
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
